Bioniche Life Sciences Inc. is a leading, fully-integrated biopharmaceutical company that discovers, develops, manufactures, and markets proprietary products for human and animal health markets worldwide.
The information contained in the Company’s news releases was accurate at the time of posting on this website, but the information may be superseded by subsequent corporate disclosures.
For recent media coverage of Bioniche Life Sciences Inc. click here >>
March 4, 2014
Bioniche Life Sciences Inc. Announces Key Corporate Updates
February 26, 2014
Vétoquinol to Acquire the Animal Health Business of Bioniche Life Sciences Inc.
February 6, 2014
Bioniche Life Sciences Inc. Reports Fiscal 2014 Second Quarter Results and Announces Strategic Expenditure Review and New One Health Strategy
Bioniche Key Facts
Dr. Michael Berendt
TSX stock symbol:
vaccines, replacement of antibiotics
One Health: E. coli O157 vaccine, other veterinary biopharmaceutical products to address diseases in livestock which may have an effect on human health